Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.

Braune SA, Wichmann D, von Heinz MC, Nierhaus A, Becker H, Meyer TN, Meyer GP, Müller-Schulz M, Fricke J, de Weerth A, Hoepker WW, Fiehler J, Magnus T, Gerloff C, Panzer U, Stahl RA, Wegscheider K, Kluge S.

Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.

PMID:
23660733
2.

Hemolytic uremic syndrome associated with Escherichia coli O157:H7 infection in older adults: a case report and review of the literature.

Ko H, Maymani H, Rojas-Hernandez C.

J Med Case Rep. 2016 Jun 15;10:175. doi: 10.1186/s13256-016-0970-z. Review.

3.

[Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome].

Ito K, Hattori M, Matsumoto N.

Nihon Rinsho. 2002 Jun;60(6):1126-30. Review. Japanese.

PMID:
12078084
4.

Hemolytic uremic syndrome associated with Shiga toxin producing Escherichia coli infection in a healthy adult woman.

Kanno Y, Kobayashi H, Rai T, Kanno K, Watanabe K, Obara K, Sato Y.

Intern Med. 2004 Jul;43(7):620-3. Review.

5.
6.

Enterohemorrhagic Escherichia coli Infections and the Hemolytic-Uremic Syndrome.

Page AV, Liles WC.

Med Clin North Am. 2013 Jul;97(4):681-95, xi. doi: 10.1016/j.mcna.2013.04.001. Review.

PMID:
23809720
7.

[Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli].

Loirat C.

Rev Prat. 2013 Jan;63(1):11-6. Review. French.

PMID:
23457821
8.

Hemolytic uremic syndrome: an emerging health risk.

Razzaq S.

Am Fam Physician. 2006 Sep 15;74(6):991-6. Review.

9.

[Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].

Ibarra C, Goldstein J, Silberstein C, Zotta E, Belardo M, Repetto HA.

Arch Argent Pediatr. 2008 Oct;106(5):435-42. doi: 10.1590/S0325-00752008000500011. Review. Spanish.

10.

Pathogenesis, treatment, and therapeutic trials in hemolytic uremic syndrome.

Trachtman H, Christen E.

Curr Opin Pediatr. 1999 Apr;11(2):162-8. Review.

PMID:
10202627
11.

Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.

Proulx F, Seidman EG, Karpman D.

Pediatr Res. 2001 Aug;50(2):163-71. Review.

PMID:
11477199
12.

Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation.

Blackall DP, Marques MB.

Am J Clin Pathol. 2004 Jun;121 Suppl:S81-8. Review.

PMID:
15298153
13.

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Scheiring J, Andreoli SP, Zimmerhackl LB.

Pediatr Nephrol. 2008 Oct;23(10):1749-60. doi: 10.1007/s00467-008-0935-6. Epub 2008 Aug 13. Review.

PMID:
18704506
14.

Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli 0111.

Azadi R, Calabrese K, Stroup J.

J Am Osteopath Assoc. 2010 Sep;110(9):538-44. Review.

PMID:
20876839
15.

Hemolytic uremic syndrome: pathogenesis and update of interventions.

Palermo MS, Exeni RA, Fernández GC.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):697-707. doi: 10.1586/eri.09.49. Review.

PMID:
19681698
16.

[Outbreak of Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome].

Kuijper EJ, Timen A, Franz E, Wessels E, van Dissel JT.

Ned Tijdschr Geneeskd. 2011;155(35):A3743. Review. Dutch.

PMID:
21902849
17.
18.

Renal and neurological involvement in typical Shiga toxin-associated HUS.

Trachtman H, Austin C, Lewinski M, Stahl RA.

Nat Rev Nephrol. 2012 Nov;8(11):658-69. doi: 10.1038/nrneph.2012.196. Epub 2012 Sep 18. Review.

PMID:
22986362
19.

A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.

Wu CJ, Hsueh PR, Ko WC.

J Microbiol Immunol Infect. 2011 Oct;44(5):390-3. doi: 10.1016/j.jmii.2011.07.001. Epub 2011 Sep 8. Review.

20.

[Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995].

Takede Y.

Nihon Rinsho. 1997 Mar;55(3):635-40. Review. Japanese.

PMID:
9086772

Supplemental Content

Support Center